Table 3.
MHC II Allele1 | Start-Stop2 | Sequence3 | Percentile Rank4 |
---|---|---|---|
TgCPB |
|
|
|
HLA-DRB1*01:01 |
10–24 |
LGTPLPFAALAAILL |
0.01 |
HLA-DRB1*01:01 |
71–85 |
ESLFDSIVAEQVVAT |
6.21 |
HLA-DRB1*01:01 |
228–242 |
LRFRYLSLKDAKKLM |
4.99 |
HLA-DRB1*01:01 |
320–334 |
SQGKRLMPLSAQHTT |
2.74 |
HLA-DRB1*01:01 |
470–484 |
SGVYKHVSGLPVGGH |
1.58 |
H2-IAb |
8–22 |
RVLGTPLPFAALAAI |
3.83 |
H2-IAb |
59–73 |
DVLNAFVSPESVESL |
3.51 |
H2-IAb |
187–201 |
VFWESRPASSNAAVA |
0.91 |
H2-IAb |
300–314 |
CGSCWAFASTEAFND |
4.46 |
H2-IAb |
549–563 |
LPGQRAAGARAGAHA |
3.19 |
H2-IAd |
15–29 |
PFAALAAILLLGCMY |
1.88 |
H2-IAd |
191–205 |
SRPASSNAAVALIKK |
4.34 |
H2-IAd |
227–241 |
SLRFRYLSLKDAKKL |
1.21 |
H2-IAd |
320–334 |
SQGKRLMPLSAQHTT |
3.19 |
H2-IAd |
428–442 |
QDTHKATSAYSLRSR |
2.52 |
H2-IEd |
182–196 |
ETGEDVFWESRPASS |
17.89 |
H2-IEd |
226–240 |
VSLRFRYLSLKDAKK |
13.43 |
H2-IEd |
351–365 |
QPGMAWRWFERKGVV |
4.77 |
H2-IEd |
399–413 |
DATLVPRKTPKCRKD |
16.82 |
H2-IEd |
432–446 |
KATSAYSLRSRDDVK |
9.89 |
TgCPL |
|
|
|
HLA-DRB1*01:01 |
60–74 |
RAWIALVAAAVSLLV |
0.04 |
HLA-DRB1*01:01 |
46–60 |
YFWKKFLRQRNFTAR |
6.00 |
HLA-DRB1*01:01 |
117–131 |
FSSFQAMYAKSYATE |
2.74 |
HLA-DRB1*01:01 |
136–150 |
RRYAIFKNNLVYIHT |
3.24 |
HLA-DRB1*01:01 |
178–192 |
LGFKKSRNLKSHHLG |
5.20 |
H2-IAb |
27–41 |
RRGVRAGRPSPPFVV |
1.49 |
H2-IAb |
59–73 |
ARAWIALVAAAVSLL |
3.37 |
H2-IAb |
85–99 |
EDDRAVFPPSPVEDH |
3.42 |
H2-IAb |
116–130 |
AFSSFQAMYAKSYAT |
5.68 |
H2-IAb |
226–240 |
CGSCWAFSTTGALEG |
2.49 |
H2-IAd |
22–36 |
GELHQRRGVRAGRPS |
6.17 |
H2-IAd |
57–71 |
FTARAWIALVAAAVS |
0.14 |
H2-IAd |
117–131 |
FSSFQAMYAKSYATE |
2.63 |
H2-IAd |
318–332 |
DVPRRSEAAMKAALA |
0.01 |
H2-IAd |
395–409 |
RDGYMYMAMHKGEEG |
1.82 |
H2-IEd |
42–56 |
TTRTYFWKKFLRQRN |
7.05 |
H2-IEd |
174–188 |
RRKYLGFKKSRNLKS |
13.03 |
H2-IEd |
202–216 |
PSELPAGVDWRSRGC |
28.28 |
H2-IEd |
309–323 |
KVVKILGFKDVPRRS |
21.70 |
H2-IEd | 376–390 | KESKKDFWIMKNSWG | 24.70 |
1 H2-IAb, H2-IAd and H2-IEd alleles are mouse MHC class II molecules; the HLA-DRB1*01:01 allele is a human MHC class II molecule.
2 We chose 15 amino acids for analysis each time.
3 TgCPB or TgCPL sequences.
4 Low percentile = high binding.